The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers.
Seung Wan SonBa Da YunMun Gyu SongJin Kyeong LeeSoo Young ChoiHyo Jeong KuhJong Kook ParkPublished in: International journal of molecular sciences (2021)
Hypoxia is one of the representative microenvironment features in cancer and is considered to be associated with the dismal prognosis of patients. Hypoxia-driven cellular pathways are largely regulated by hypoxia-inducible factors (HIFs) and notably exert influence on the hallmarks of cancer, such as stemness, angiogenesis, invasion, metastasis, and the resistance towards apoptotic cell death and therapeutic resistance; therefore, hypoxia has been considered as a potential hurdle for cancer therapy. Growing evidence has demonstrated that long noncoding RNAs (lncRNAs) are dysregulated in cancer and take part in gene regulatory networks owing to their various modes of action through interacting with proteins and microRNAs. In this review, we focus attention on the relationship between hypoxia/HIFs and lncRNAs, in company with the possibility of lncRNAs as candidate molecules for controlling cancer.
Keyphrases
- papillary thyroid
- cell death
- endothelial cells
- squamous cell
- long noncoding rna
- lymph node metastasis
- end stage renal disease
- chronic kidney disease
- drug delivery
- network analysis
- newly diagnosed
- epithelial mesenchymal transition
- squamous cell carcinoma
- young adults
- ejection fraction
- transcription factor
- peritoneal dialysis
- cell proliferation
- vascular endothelial growth factor
- wound healing
- cell cycle arrest